Fresenius Medical Care (FMC) St. Aktie
38,41
EUR
+0,17
EUR
+0,44
%
Fresenius Medical Care (FMC) St. jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Diese Analysten bewerten die Fresenius Medical Care (FMC) St.-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 37,40 EUR | - | 13.03.2026 | |
| DZ BANK | - | - | 13.03.2026 | |
| Barclays Capital | 46,50 EUR | - | 12.03.2026 | |
| UBS AG | 37,00 EUR | - | 10.03.2026 | |
| Deutsche Bank AG | 42,00 EUR | - | 02.03.2026 | |
| Jefferies & Company Inc. | 32,00 EUR | - | 02.03.2026 | |
| Goldman Sachs Group Inc. | 40,00 EUR | - | 24.02.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 60,00 EUR | - | 03.12.2025 | |
| Bernstein Research | 54,50 EUR | - | 20.10.2025 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Baxter International Inc. | 0 | 0 | 0 | - | - |
| BB MEDTECH AG | 0 | 0 | 0 | - | - |
| Becton, Dickinson & Co. (BD) | 0 | 0 | 0 | - | - |
| Boston Scientific Corp. | 0 | 0 | 0 | - | - |
| Carl Zeiss Meditec AG | 1 | 8 | 1 | 33,54 EUR | - |
| DaVita Inc Registered Shs | 0 | 0 | 0 | - | - |
| Drägerwerk AG & Co. KGaA Vz. | 1 | 2 | 0 | 79,00 EUR | - |
| Fresenius Medical Care (FMC) St. | 2 | 4 | 3 | 43,68 EUR | - |
| Fresenius SE & Co. KGaA (St.) | 7 | 2 | 0 | 54,32 EUR | - |
| General Electric Co. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Medtronic PLC | 0 | 0 | 0 | - | - |
| Novartis AG | 3 | 5 | 1 | 116,88 CHF | -1,67% |
| Philips N.V. | 4 | 5 | 0 | 27,25 EUR | +17,76% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Siemens AG | 6 | 2 | 2 | 252,62 EUR | - |
| Smith & Nephew plc | 0 | 0 | 0 | - | - |
| St. Jude Medical Inc. | 0 | 0 | 0 | - | - |
| STRATEC SE | 1 | 2 | 0 | 30,00 EUR | +63,04% |
| Synthes Inc. | 0 | 0 | 0 | - | - |
| Zimmer Biomet | 0 | 0 | 0 | - | - |